Michael D. Clayman, President and CEO at Flexion Therapeutics Inc (FLXN), bought 24,683 shares at $17.10 ($86K) on 2018-11-09, disclosed to the SEC on 2018-11-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 10,562 | $0 | 0.0% |
| 2 | $0.00 | 554 | $0 | 0.0% |
| 3 | $0.00 | 8,567 | $0 | 0.0% |
| 4 | $17.10 | 5,000 | $86K | 100.0% |
| Total | $3.46 avg | 24,683 | $86K | 100% |
| Filing → |
| FLXN | BUY | 2019-05-13 | $100K | — | Filing → |
| FLXN | BUY | 2019-03-13 | $100K | — | Filing → |
| FLXN | SELL | 2019-01-04 | $41K | — | Filing → |